Related Experiment Video
Updated: Aug 30, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Thrombolysis in the management of lower limb peripheral arterial occlusion--a consensus document
Insights
This consensus establishes guidelines for thrombolytic therapy in lower limb occlusive peripheral arterial disease. It provides recommendations for clinical practice and reporting, aiming to improve patient outcomes.
Area of Science:
- Vascular Medicine
- Interventional Radiology
- Hematology
Background:
- Occlusive peripheral arterial disease (PAD) of the lower limbs requires effective treatment strategies.
- Thrombolytic therapy offers a potential solution for restoring blood flow in acute limb ischemia.
- Establishing consensus on its use is crucial for standardized patient care.
Framework:
- An intercontinental working party of vascular specialists developed consensus recommendations.
- The process involved multiple meetings, data review, and input from professional societies.
- Guidelines were formulated based on available scientific and practical data.
Implementation:
- Recommendations cover the clinical use of thrombolytic agents for lower limb PAD.
- The guidelines address the reporting of outcomes for thrombolytic therapy.
- Focus is on drugs currently approved for clinical use.
Implications:
- This consensus aims to standardize thrombolytic therapy for lower limb PAD.
- It provides a framework for clinical decision-making and research.
- The recommendations may encourage regulatory approval of thrombolytic agents for intra-arterial use.
Abstract:
The aim of this paper is to develop an intercontinental consensus on the use of thrombolytic therapy in occlusive peripheral arterial disease affecting lower limbs. A working party of self-designated angiologists, hematologists, interventional radiologists, and vascular surgeons of Europe and North America convened at 4 closed meetings. All published data known to any of the participants was entered into discussion. The working party discussed the topics outlined in this paper and a first draft was prepared in segments by members of the working party, discussed, and further revised into an interim report. It was then circulated to a number of Societies for their input. A final meeting of the Working Party together with delegates of the Societies collaborated on the definitive version of the text. The Party appreciates that in many areas the scientific evidence is not yet available. Nevertheless, it was felt that enough practical and scientific data were available to establish recommendations for clinical practice as well as for reporting results of thrombolytic therapy, which could be updated as later evidence became available. The guidelines apply only to drugs currently available for clinical use. The data are also considered to be sufficiently cogent that regulatory agencies should move to approve thrombolytic agents for intra-arterial therapy of acute lower extremity ischemia.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Venous Thrombosis IV: Nursing Management

